Compounds, compositions, and methods for increasing CFTR activity
US10392372B2 · kind B2 · utility
6Cited by
11References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 23, 2015 |
| Grant date | Aug 27, 2019 |
| Priority date | — |
| Expiry date | Dec 23, 2035 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N33/5044
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure is directed to disclosed compounds that increase cystic fibrosis transmembrane conductance regulator (CFTR) activity as measured in human bronchial epithelial (hBE) cells.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.